burger

A pharmaceutical company
specialising in biological
medicinal products

3 fields of therapy
  • Immunology
  • Haemostasis
  • Intensive Care

Group executive commitee

Committee’s composition
3

Bioproduction sites in France

92/100

This is the professional gender equality index obtained by LFB

15 medicines

prescribed to

hospital

€ 400 M in turnover

in 2018

22

medical specialties that regularly use
LFB’s medicines

1 st in France

in the field
of plasma-derived
medicinal products

Meeting with

Denis DELVAL ,
Chairman and CEO of the LFB Group

" my ambition is to build the future of the Group with the men and women of the LFB. "

LFB attends French and international conferences

All news

2:11

LFB Group corporate film 2019

Living with peripheral neuropathies, a video supported by LFB

All videos

LFB attends French and international conferences

Discover the 2019 LFB corporate video

LFB strategic transformation project

LFB joins the World Hemophilia Day 2019, today April 17th.

LFB completes the sale of CELLforCURE to Novartis

CELLforCURE will produce innovative cancer CAR-T treatments for Novartis
92/100

This is the professional gender equality index obtained by LFB
15 medicines

prescribed to

hospital
3

Bioproduction sites in France
1st in France

in the field
of plasma-derived
medicinal products

Living with peripheral neuropathies, a video supported by LFB

there is 1 year

2:11

LFB Group corporate film 2019

there is 4 years

Group executive commitee

Committee’s composition